Chemistry - A European Journal · 2019 · 17 citations · 94 references
Natural SciencesChemistryMedicinal ChemistryCatalysisOrganic ChemistrySynthetic Medicinal ChemistryDiversity-oriented SynthesisHeterocyclic ChemistryAsymmetric SynthesisCatalytic MotifCatalytic SynthesisDynamic Nmr SpectroscopyEnantioselective SynthesisTransformations
Chiral α,α-difluoromethyl carbinols are recurring structural motifs in many therapeutic agents. Despite the indubitable interest in the catalytic asymmetric synthesis of such compounds, this research field still remains largely underexplored. Herein, an efficient approach to a range of chiral homopropargylic α,α-difluoromethyl carbinols has been developed, through a Cu-catalyzed enantioselective propargylation of α,α-difluoroketones with (pinacolato)allenylboron. In the presence of a cuprous complex, generated in situ from CuCl and a spiroketal-based diphosphine (SKP) ligand, a variety of aryl-, heteroaryl-, alkyl-, alkynyl, alkenyl, or benzyloxycarbonyl-substituted α,α-difluoromethyl carbinols were obtained in 75-99 % yields with 84-98 % ee values. The catalytic system was further investigated using a combined dynamic NMR spectroscopic, X-ray crystallographic, and non-linear effect studies. The origin of the enantioselectivity was rationalized based on DFT calculations. Finally, several efficient transformations were showcased to highlight the utilities of the protocol in synthesis of complex compounds bearing an α,α-difluoromethyl carbinol moiety.
94
Evaluation of the antitumor activity of gemcitabine (2',2'-difluoro-2'-deoxycytidine).
Larry W. Hertel, G B Boder, Julian S. Kroin et al. · PubMed · 1990 · 683 citations
Medicine, Oncology, Pharmacology +11
Gary Herman, C. Melinda Stevens, Koen Vandyck et al. · Clinical Pharmacology & Therapeutics · 2005 · 519 citations
Kevin D. Courtney, Jeffrey R. Infante, Elaine T. Lam et al. · Journal of Clinical Oncology · 2017 · 390 citations · Full text
Medicine, Oncology, Pharmacology +16